Out-of-pocket payments and loss of income among long-term breast cancer survivors in Germany: a multi-regional population-based study

Author:

Schneider Jana,Hernandez DiegoORCID,Schlander Michael,Arndt Volker, ,

Abstract

Abstract Purpose This study aims to examine the magnitude of out of pocket (OOP) payments and income loss, as well as to identify socioeconomic and clinical factors among long-term breast cancer (BC) survivors in Germany. Methods We examine data from 2654 long-term BC survivors in Germany that participated in the “CAncEr Survivorship – A multi-Regional population-based study” (CAESAR) and who were at least 5 years post diagnosis. BC-related OOP payments and income loss both within the 12 months prior to the survey were analyzed. Two-part regression models were performed to identify socioeconomic and clinical factors. Results OOP payments were incurred by 51.9% of survivors with a total mean spending of 566 euros. Income loss was present among 9.6% of survivors and averaged 5463 euros among those reporting such. Socioeconomic and clinical factors associated with higher OOP payments (p ≤ 0.05) included age at time of diagnosis (65–79 years), education (10–11 years), (early) retirement, stage of diagnosis (stage III), time from diagnosis (more than 10 years), comorbidities (at least 1), and the use of rehabilitation services. Regarding income loss, age at time of diagnosis (50–59 years), (early) retirement, stage of diagnosis (stage II), time from diagnosis (5–7 years), comorbidities (at least 1), and receiving chemotherapy treatment were associated with higher losses. Conclusions For some survivors in Germany, financial burden can be considerably high despite comprehensive healthcare and support from social security. Implications for Cancer Survivors OOP payments related to domestic help and nursing staff as well as to outpatient care are most frequent.

Funder

Deutsche Krebshilfe

Deutsches Krebsforschungszentrum (DKFZ)

Publisher

Springer Science and Business Media LLC

Subject

Oncology (nursing),Oncology

Reference92 articles.

1. Erdmann F, Spix C, Katalinic A, Christ M, Folkerts J, Hansmann J, et al. Krebs in Deutschland für 2017/2018. Berlin: Robert-Koch-Institut; 2021. p. 13.

2. Katalinic A, Eisemann N, Kraywinkel K, Noftz MR, Hübner J. Breast cancer incidence and mortality before and after implementation of the German mammography screening program. Int J Cancer. 2020;147(3):709–18.

3. Zentrum für Krebsregisterdaten (ZfKD). Krebs gesamt. ICD-10 C00-C97 [internet]. Berlin: ZfKD RKI; 2022 [updated 22.09.2022]. Available from: https://www.krebsdaten.de/Krebs/DE/Content/Krebsarten/Krebs_gesamt/krebs_gesamt_node.html.

4. Arndt V. “Cancer survivorship” in Deutschland – Epidemiologie und Definitionen. Forum. 2019;34(2):158–64.

5. Arndt V, Dahm S, Kraywinkel K. Krebsprävalenz in Deutschland 2017. Onkologe. 2021;27(8):717–23.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3